Neptune Wellness Solutions Inc. (NASDAQ:NEPT) shares traded 75.69% higher at $0.24 on Wall Street last session.
In accordance with the data, 1 analysts cover Neptune Wellness Solutions Inc. (NASDAQ:NEPT). The consensus rating among analysts is ‘Hold’. As we calculate the median target price by taking the range between a high of $21.94 and a low of $21.94, we find $21.94. Given the previous closing price of $0.14, this indicates a potential upside of 15571.43 percent. NEPT stock price is now 63.61% away from the 50-day moving average and -48.83% away from the 200-day moving average. The market capitalization of the company currently stands at $1.70M.
It has been rated a hold by 1 analysts and a buy by 0. Brokers who have rated the stock have averaged $21.94 as their price target over the next twelve months.
Insiders disposed of 34,348 shares of company stock worth roughly $8243.52 over the past 1 year. A total of 3.50% of the company’s stock is owned by insiders.
There have been several recent changes in the stakes of large investors in NEPT stock. A new stake in Neptune Wellness Solutions Inc. shares was purchased by WARBERG ASSET MANAGEMENT LLC during the first quarter worth $61,000. TWO SIGMA SECURITIES, LLC invested $11,000 in shares of NEPT during the first quarter. In the first quarter, JPMORGAN CHASE & CO acquired a new stake in Neptune Wellness Solutions Inc. valued at approximately $2,000. In total, there are 29 active investors with 6.20% ownership of the company’s stock.
Neptune Wellness Solutions Inc. (NASDAQ: NEPT) opened at $0.2520 on Friday. During the past 12 months, Neptune Wellness Solutions Inc. has had a low of $0.11 and a high of $3.74. The fifty day moving average price for NEPT is $0.1484 and a two-hundred day moving average price translates $0.4681 for the stock.
The latest earnings results from Neptune Wellness Solutions Inc. (NASDAQ: NEPT) was released for Jun, 2023. According to the Drug Manufacturers – Specialty & Generic Company, earnings per share came in at -$0.22, beating analysts’ expectations of -$0.28 by 0.06. This compares to -$1.09 EPS in the same period last year. The net profit margin was -72.60% and return on equity was -270.70% for NEPT. The company reported revenue of $10.63 million for the quarter, compared to $16.27 million a year earlier. Comparatively to last year’s same quarter, the company’s quarterly revenue fell -34.69 percent.
Neptune Wellness Solutions Inc.(NEPT) Company Profile
Neptune Wellness Solutions Inc. operates as a consumer packaged goods company in Canada, the United States, and internationally. It’s product portfolio includes omega-3 fish oils and other nutritional products, as well as softgel solutions under the Biodroga brand; and provides MaxSimil, an omega-3 fatty acid delivery technology that uses enzymes to predigest omega-3 fatty acids. The company offers vegan multi-omega gummies and soft gels under the Forest Remedies brand; and organic baby food products under the Sprout brands. It offers its products through distributors, retail outlets, and grocery stores, as well as online on forestremedies.com and sproutorganics.com, and e-commerce sites. Neptune Wellness Solutions Inc. was incorporated in 1998 and is headquartered in Laval, Canada.
